Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype

Cystic fibrosis (CF) is a life-shortening disease arising as a consequence of mutations within the CFTR gene. Novel therapeutics for CF are emerging that target CF transmembrane conductance regulator protein (CFTR) defects resulting from specific CFTR variants. Ivacaftor is a drug that potentiates C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Clancy, J P, Johnson, S G, Yee, S W, McDonagh, E M, Caudle, K E, Klein, T E, Cannavo, M, Giacomini, K M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2014
Assuntos:
CPIC Guidelines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4026598/
https://ncbi.nlm.nih.gov/pubmed/24598717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2014.54
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados